EUVIMEDEUVIMED entdecken
Open Access

Bipolar II disorder: a state‐of‐the‐art review

Michael Berk, Asier Corrales, Roth Trisno, Seetal Dodd, Lakshmi N Yatham, Eduard Vieta, Roger S McIntyre, Trisha Suppes, Bruno Agustini

World Psychiatry · 2025-06 · 24 (2) · 175-189

DOI: 10.1002/wps.21300 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Psychiatry, online erschienen am 15.05.2025. Verfasst von Michael Berk und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Mental and Physical Health and Clinical Translation (IMPACT), School of Medicine, Deakin University, Barwon Health, Geelong, VIC, Austr…. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 258 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bipolar II disorder (BD‐II) is currently identified by both the DSM‐5 and ICD‐11 as a distinct subtype of bipolar disorder, defined by at least one depressive episode and at least one hypomanic episode, with no history of mania. Despite its prevalence and impact, the literature on BD‐II remains relatively sparse. This paper provides a comprehensive overview of the available research and current debate on the disorder, including its diagnostic criteria, clinical presentations, comorbidities, epidemiology, risk factors, and treatment strategies. Patients with BD‐II often present with recurrent depressive episodes, which outnumber hypomanic episodes by a ratio of 39:1. The condition is therefore often misdiagnosed as major depressive disorder and treated with antidepressant monotherapy, which may worsen its prognosis. The recognition of BD‐II is further complicated by the overlap of its symptoms with other disorders, in particular borderline personality disorder. Although BD‐II is often perceived as a less severe form of bipolar disorder, evidence suggests significant functional and cognitive impairment, accompanied by an elevated risk of suicidal behavior, including a rate of completed suicide at least equivalent to that observed in bipolar I disorder (BD‐I). Psychiatric comorbidities, in particular anxiety and substance use disorders, are common. The disorder is associated with a high prevalence of numerous physical comorbidities, with a particularly high risk of comorbid cardiovascular diseases. Various genetic and environmental risk factors have been identified. Inflammation, circadian rhythm dysregulation and mitochondrial dysfunction are being studied as potential pathophysiological mechanisms. Current treatment guidelines, often extrapolated from BD‐I and depression research, may not fully address the unique aspects of BD‐II. Nevertheless, substantial evidence supports the value of some pharmacological treatments – primarily mood stabilizers and atypical antipsychotics – augmented by psychoeducation, cognitive behavioral or interpersonal and social rhythm therapy, and lifestyle interventions. Further research on BD‐II should be a priority, in order to refine diagnostic criteria, identify potentially modifiable risk factors, and develop targeted interventions.

Schlagwörter

Stichwörter der Autor:innen

Bipolar disorderbipolar II disorderborderline personality disorderdepressionhypomaniamisdiagnosismitochondrial dysfunctionmixed statesmood stabilizerspsychoeducationsuicidal behavior

Autor:innen und Institutionen

  • Institute for Mental and Physical Health and Clinical Translation (IMPACT), School of Medicine, Deakin University, Barwon Health, Geelong, VIC, Australia.
  • Mental Health, Drugs and Alcohol Service, Barwon Health, Geelong, VIC, Australia.
  • Department of Psychiatry, Navarra University Hospital, Pamplona, Spain.
  • Mental Health Department, Navarra Health System - Osasunbidea, Pamplona, Spain.
  • Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  • Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada.

Zitieren

APA

Berk, M., Corrales, A., Trisno, R., Dodd, S., Yatham, L. N., Vieta, E., McIntyre, R. S., Suppes, T., & Agustini, B. (2025). Bipolar II disorder: a state‐of‐the‐art review. World Psychiatry, 24(2), 175-189. https://doi.org/10.1002/wps.21300

Vancouver

Berk M, Corrales A, Trisno R, Dodd S, Yatham LN, Vieta E, et al. Bipolar II disorder: a state‐of‐the‐art review. World Psychiatry. 2025;24(2):175-189. doi:10.1002/wps.21300

BibTeX
@article{Berk2025,
  author = {Berk, Michael and Corrales, Asier and Trisno, Roth and Dodd, Seetal and Yatham, Lakshmi N and Vieta, Eduard and McIntyre, Roger S and Suppes, Trisha and Agustini, Bruno},
  title = {Bipolar II disorder: a state‐of‐the‐art review},
  journal = {World Psychiatry},
  year = {2025},
  volume = {24},
  number = {2},
  pages = {175--189},
  doi = {10.1002/wps.21300}
}
Kostenlos starten →